The Vanderbilt Specialty Pharmacy Health Outcomes and Research Program was established to improve patient care through sound research while furthering innovation and insights within the field of specialty pharmacy.
We focus on the link between specialty pharmacy medications, health care delivery and patient outcomes by performing research that encompasses the complete patient journey, from evaluation through treatment. Specifically, we are committed to:
- Improving medication access, adherence and health outcomes of Vanderbilt Specialty Pharmacy patients
- Utilizing research findings to improve optimal care delivery through timely, positive patient service
Vanderbilt Specialty Pharmacy
- Collaborating with manufacturers of specialty agents and payers insuring specialty patients on outcomes research efforts
- Increasing access to limited distribution drugs and payers to better serve Vanderbilt University Medical Center patients
Specialty Pharmacy Profession
- Evaluating and reporting the value of specialty pharmacy services to patients, providers and the healthcare community
- Supporting and enhancing the role of Vanderbilt Specialty Pharmacy pharmacists as thought leaders in their fields of clinical research
- Advocating for health-system specialty pharmacy recognition as an optimal care delivery model for specialty patients
We are uniquely positioned to produce rigorous, innovative, meaningful outcomes research. Our outcomes program leverages the expertise and experience of world-renowned physician champions within the Vanderbilt University Medical Center. We also fuel our efforts through a partnership with the Department of Biostatistics, a collaborative population health department and a cutting edge Health IT department to ensure our projects are solid and sound.
Autumn Zuckerman, PharmD, BCPS, AAHIVP, CSP
Megan Peter, PhD
Nisha Shah, PharmD
- Association of Managed Care and Specialty Pharmacy Annual Meeting
- Gold ribbon abstract winners
- A Targeted Approach to Reducing Rates of Discontinuation and Dose Reduction in Patients Receiving Sorafenib or Regorafenib
- Development of a Collaborative Pharmacy Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic
- American College of Gastroenterology Meeting
- Recognized as Best of ACG 2018 IBD & Liver
- Risk Factors for Non-Adherence to Biologic Therapy in Adult Patients with Inflammatory Bowel Disease (IBD): A Retrospective Analysis
- Academy of Managed Care and Specialty Pharmacy Nexus Meeting
- Silver Ribbon Abstract
- Closing the Gap: Identifying Rates and Reasons for Nonadherence in a Specialty Population
- National Association of Specialty Pharmacy Annual Meeting
- Third place abstract winner
- Assessing the Impact of High Touch Specialty Pharmacy Services in Patients Receiving Teriparatide
CONTACTWant to learn more about Vanderbilt Specialty Pharmacy’s Outcomes Program? Interested in partnering with us on a current or future project? We would love to hear from you!
Please fill out the form and we will be in touch!